Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

NCT00106964 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

371

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection
Hepatitis B

Interventions

BIOLOGICAL: Engerix-B 20 mcg
BIOLOGICAL: Engerix-B 40 mcg
BIOLOGICAL: Twinrix 720 EIA HAV Ag plus 20 mcg HBsAg

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]
[object Object]
[object Object]